Abstract | OBJECTIVE: STUDY DESIGN: RESULTS: Both treatment regimens effectively relieved climacteric symptoms. Spotting was more common in the intrauterine contraceptive device group than in the oral therapy group for the first 3 months. After that, the proportion of women without any bleeding was similar in both groups. Two patients in each group dropped out because of bleeding. CONCLUSION:
|
Authors | T H Raudaskoski, E I Lahti, A J Kauppila, M A Apaja-Sarkkinen, T J Laatikainen |
Journal | American journal of obstetrics and gynecology
(Am J Obstet Gynecol)
Vol. 172
Issue 1 Pt 1
Pg. 114-9
(Jan 1995)
ISSN: 0002-9378 [Print] United States |
PMID | 7847516
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Administration, Cutaneous
- Administration, Oral
- Adult
- Climacteric
(drug effects)
- Endometrium
(drug effects, pathology)
- Estradiol
(administration & dosage, therapeutic use)
- Estrogen Replacement Therapy
- Female
- Humans
- Intrauterine Devices
- Levonorgestrel
(administration & dosage, therapeutic use)
- Middle Aged
- Uterine Hemorrhage
(physiopathology)
|